# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Cody Ross maintains Ingredion (NYSE:INGR) with a Buy and raises the price target from $141 to $148.
Barclays analyst Benjamin Theurer upgrades Ingredion (NYSE:INGR) from Equal-Weight to Overweight and raises the price target...
BMO Capital analyst Andrew Strelzik maintains Ingredion (NYSE:INGR) with a Market Perform and raises the price target from $...
Oppenheimer analyst Kristen Owen maintains Ingredion (NYSE:INGR) with a Outperform and raises the price target from $126 to ...
Ingredion (NYSE:INGR) reported quarterly earnings of $2.87 per share which beat the analyst consensus estimate of $2.49 by 15.2...
Ingredion Incorporated (NYSE:INGR), a global provider of specialty ingredients and innovation leader in plant-based sugar redu...